首頁 > 市場調查報告書 > 製藥

生技設備生物工藝

市場調查報告書

商品編碼

1618228

生物過程分析儀市場機會、成長促進因素、產業趨勢分析與預測 2024 - 2032 年

Bioprocess Analyzers Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2024 - 2032

出版日期: 2024年10月07日 | 出版商:

Global Market Insights Inc. | 英文 132 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2023 年，全球生物過程分析儀市場估值為20 億美元，預計2024 年至2032 年複合年成長率為11.5%。細胞或其細胞。這些分析儀有助於提高生物技術過程的品質、效率和控制，特別是在生物製品生產中。生物技術的不斷進步導致了更複雜和自動化的生物過程分析儀的開發，進一步推動了市場的成長。此外，由於生物相似藥與生物製劑相比具有成本效益，對生物相似藥的需求不斷成長，是重要的市場成長動力。

政府的支持和資助也促進了該領域的創新，凸顯了這些工具在生物製藥產業中日益重要的重要性。根據分析類型，濃度檢測成為領先領域，到 2023 年將產生 11 億美元的收入，預計複合年成長率為 11.6%。包括單株抗體和疫苗在內的生物製品生產依賴於蛋白質、代謝物和細胞密度等關鍵參數的準確測量。這推動了對能夠確保一致的產品品質和法規遵循的分析儀的需求。

依應用，市場分為抗生素、重組蛋白、生物相似藥和其他生物製品。到 2023 年，抗生素領域將佔據 30.8% 的市場佔有率，預計在預測期內將以 10.2% 的複合年成長率成長。抗生素生產涉及複雜的微生物發酵過程，需要精確的環境控制。生物製程分析儀配備先進的感測器，有助於監測和維持最佳發酵條件，例如氧氣水平、營養供應和溫度，最終提高生產效率。

市場範圍
開始年份	2023年
預測年份	2024-2032
起始值	20億美元
預測值	54億美元
複合年成長率	11.5%

就區域成長而言，預計到 2032 年，北美生物過程分析儀市場將達到 20 億美元。癌症、糖尿病和自體免疫疾病等慢性病的盛行率不斷上升，推動了對生物製劑和個人化藥物的需求。這反過來又增加了對生物過程分析儀的需求，以改善生產過程並在這些先進療法的開發中保持法規遵循。

產業生態系統分析
產業影響力
- 成長動力
  - 對生物製藥產品的需求不斷成長
  - 生物技術和生物加工的進步
  - 對生物相似藥的需求不斷增加
  - 政府措施和資金不斷增加
- 產業陷阱與挑戰
  - 儀器成本高
  - 複雜性和技術專長
成長潛力分析
監管環境
- 美國
- 歐洲
- 亞太地區
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
主要市場參與者的競爭分析
競爭定位矩陣
戰略儀表板
戰略展望矩陣

第 5 章：市場估計與預測：按產品分類，2021 - 2032 年

主要趨勢
儀器儀表
耗材及配件

第 6 章：市場估計與預測：按分析類型，2021 - 2032 年

主要趨勢
底物分析
代謝物分析
濃度檢測

第 7 章：市場估計與預測：按應用分類，2021 - 2032

主要趨勢
抗生素
重組蛋白
生物相似藥
其他應用

第 8 章：市場估計與預測：按最終用途，2021 - 2032 年

主要趨勢
生物製藥公司
CRO 和 CMO
研究與學術機構
其他最終用途

第 9 章：市場估計與預測：按地區，2021 - 2032

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 西班牙
- 義大利
- 歐洲其他地區
亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 10 章：公司簡介

4BioCell GmbH & Co. KG
Agilent Technologies, Inc.
Danaher Corporation
Endress+Hauser Group Services AG
Eppendorf AG
F. Hoffmann-La Roche Ltd.
Nova Biomedical
Randox Laboratories Ltd.
Sartorius AG
Solida Biotech GmBH
SYSBIOTECH GmbH
Thermo Fisher Scientific Inc.
Xylem Inc.

簡介目錄

Product Code: 8765

The Global Bioprocess Analyzers Market was valued at USD 2 billion in 2023 and is projected to grow at a CAGR of 11.5% from 2024 to 2032. Bioprocess analyzers are essential tools used to monitor and optimize bioprocesses, which involve the use of living cells or their components to produce products such as biopharmaceuticals, biofuels, and other biotechnology-driven goods. These analyzers help improve the quality, efficiency, and control of biotechnological processes, especially in biologics production. The ongoing advancements in biotechnology have led to the development of more sophisticated and automated bioprocess analyzers, further fueling market growth. Additionally, the growing demand for biosimilars, owing to their cost-efficiency compared to biologics, is a significant market growth driver.

Government support and funding also foster innovation in this sector, underscoring the increasing importance of these instruments in the biopharmaceutical industry. Based on analysis type, concentration detection emerged as the leading segment, generating USD 1.1 billion in revenue in 2023, with expectations for continued growth at a CAGR of 11.6%. Biologics production, including monoclonal antibodies and vaccines, relies on accurate measurements of critical parameters such as proteins, metabolites, and cell densities. This drives the demand for analyzers that can ensure consistent product quality and regulatory compliance.

By application, the market is divided into antibiotics, recombinant proteins, biosimilars, and other bioproducts. The antibiotics segment accounted for a significant 30.8% market share in 2023 and is anticipated to grow at a 10.2% CAGR over the forecast period. Antibiotic production involves intricate microbial fermentation processes that require precise environmental control. Bioprocess analyzers, equipped with advanced sensors, help monitor and maintain optimal fermentation conditions, such as oxygen levels, nutrient feed, and temperature, ultimately enhancing production efficiency.

Market Scope
Start Year	2023
Forecast Year	2024-2032
Start Value	$2 Billion
Forecast Value	$5.4 Billion
CAGR	11.5%

In terms of regional growth, the North American bioprocess analyzers market is expected to reach USD 2 billion by 2032. The U.S. led the regional market in 2023, with a revenue share of USD 712.7 million. The increasing prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders is driving the demand for biologics and personalized medicines. This, in turn, is boosting the need for bioprocess analyzers to improve production processes and maintain regulatory compliance in the development of these advanced therapies.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Growing demand for biopharmaceutical products
  - 3.2.1.2 Advancements in biotechnology and bioprocessing
  - 3.2.1.3 Increasing demand for biosimilars
  - 3.2.1.4 Rising government initiatives and funding
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of instruments
  - 3.2.2.2 Complexity and technical expertise
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 U.S.
- 3.4.2 Europe
- 3.4.3 Asia Pacific
3.5 Technological landscape
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
4.6 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Instruments
5.3 Consumables & accessories

Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Substrate analysis
6.3 Metabolite analysis
6.4 Concentration detection

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Antibiotics
7.3 Recombinant proteins
7.4 Biosimilars
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 Biopharmaceutical companies
8.3 CROs & CMOs
8.4 Research & academic institutes
8.5 Other End Use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

9.1 Key trends
9.2 North America
- 9.2.1 U.S.
- 9.2.2 Canada
9.3 Europe
- 9.3.1 Germany
- 9.3.2 UK
- 9.3.3 France
- 9.3.4 Spain
- 9.3.5 Italy
- 9.3.6 Rest of Europe
9.4 Asia Pacific
- 9.4.1 China
- 9.4.2 Japan
- 9.4.3 India
- 9.4.4 Australia
- 9.4.5 South Korea
- 9.4.6 Rest of Asia Pacific
9.5 Latin America
- 9.5.1 Brazil
- 9.5.2 Mexico
- 9.5.3 Argentina
- 9.5.4 Rest of Latin America
9.6 Middle East and Africa
- 9.6.1 South Africa
- 9.6.2 Saudi Arabia
- 9.6.3 UAE
- 9.6.4 Rest of Middle East and Africa